ABclonal

About:

ABclonal is a biotechnology company that is a supplier of global antibody and molecular enzyme reagents.

Website: https://abclonal.com/

Twitter/X: ABclonal_USA

Top Investors: HongShan, Oriza Fund of Funds, LYFE Capital, CMB International Capital Corporation, Loyal Valley Capital

Description:

ABclonal Technology is a rapidly growing life science research and diagnostic reagents provider. With scientists from world-class universities, the company thrives on improving the quality of life science research by providing high-quality antibodies, proteins, ELISA kits, NGS library preparation kits and molecular enzymes.

Total Funding Amount:

$282M

Headquarters Location:

Wuhan, Hubei, China

Founded Date:

2011-01-01

Contact Email:

info(AT)abclonal.com

Founders:

Number of Employees:

501-1000

Last Funding Date:

2021-12-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai